Cardiovascular disease remains the world's top killer, but early detection through better blood testing could dramatically ...

Researchers in Sweden and the US suggest measuring levels of lipoproteins may be a more accurate risk predictor.

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of ...

New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...

A simple blood test for "bad" cholesterol proteins could be a more accurate risk predictor of cardiovascular disease ...

Background: Differences exist between European and American guideline recommendations regarding targets for low-density lipoprotein cholesterol (LDL-C) levels after percutaneous coronary intervention ...

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in early trials. Here's what you need to know about the condition and the ...

An estimated 64 million Americans have elevated levels of lipoprotein(a), or Lp(a), a type of cholesterol that can increase the risk of heart attack and other cardiovascular problems. Having high ...

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of cardiovascular disease.

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...